RareCyte Garners New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=99e3c32f-797a-4e52-ac78-25b2818b3c97&Preview=1 -
Date
8/22/2012 -
Company Name
RareCyte -
Mailing Address
228 9th Avenue North Seattle, WA 98109 -
Company Description
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. Our team of biologists and engineers is dedicated to building innovative technologies to better understand human health and disease. -
Website
http://www.rarecyte.com -
Transaction Type
Venture Equity -
Transaction Amount
Undisclosed -
Transaction Round
Undisclosed -
Proceeds Purposes
RareCyte plans to use the funds to complete the final stages of product development and initiate the platform’s commercial launch in the research oncology market. -
M&A Terms
-
Venture Investor
Telegraph Hill Partners -
Venture Investor
Undisclosed
